Global Diabetes Management Apps Market - 2025-2033

Best Price Guarantee	Length	Publisher	Published Date	SKU
from $4,350	192 Pages	DataM Intelligence 4Market Research LLP	March, 2025	DTAM19805019

Best Price Guarantee
Price	from $4,350
Length	192 Pages
Publisher	DataM Intelligence 4Market Research LLP
Published Date	March, 2025
SKU	DTAM19805019

The global diabetes management apps market reached US$ 1.37 billion in 2024 and is expected to reach US$ 9.90 billion by 2033, growing at a CAGR of 24.7% during the forecast period 2025-2033.

Diabetes management apps are mobile applications designed to help individuals with diabetes monitor and manage their condition. These apps serve as digital tools to assist users in tracking and managing key health metrics related to diabetes, such as blood glucose levels, medication, diet, physical activity, and overall health status. These apps aim to provide individuals with the support needed to make informed decisions regarding their diabetes care, improve adherence to prescribed treatments, and ultimately help reduce the risk of diabetes-related complications.

Market Dynamics: Drivers & Restraints

Rising prevalence of diabetes

The rising prevalence of diabetes is significantly driving the growth of the diabetes management apps market and is expected to drive the market over the forecast period. According to the International Diabetes Federation (IDF, approximately 537 million adults (20-79 years old) were living with diabetes in 2021, and this number is expected to increase to 783 million by 2045. This growing number of people with diabetes creates a large and expanding market for diabetes management tools like apps. As more individuals are diagnosed, the demand for accessible, efficient, personalized management solutions rises.

Diabetes requires continuous monitoring and management of blood glucose levels, medication, diet, and lifestyle. Traditional methods, including frequent visits to healthcare providers, can be time-consuming and costly. Diabetes management apps help bridge this gap by offering users the ability to monitor their condition on a day-to-day basis through their smartphones, thus ensuring they can manage their diabetes more effectively and reduce the risk of complications such as hypoglycemia, cardiovascular issues, and kidney problems, among others.

For instance, mySugr, with more than four million registered users globally and availability in over 80 countries and 24 languages, is one of the world’s most popular diabetes management apps. The app integrates data from glucose meters and insulin pumps to provide personalized recommendations, helping users track their condition more effectively.

Data privacy and security concerns

Data privacy and security concerns are significant factors hampering the growth of the diabetes apps market. Since these apps handle sensitive health information, including personal data, blood glucose levels, medication records, and other health metrics, the risk of data breaches, unauthorized access, and misuse raises concerns among potential users, healthcare providers, and regulators.

For instance, according to the HIPAA Journal, in August 2023, 23 million breached healthcare records were noticed. Over the past 12 months, an average of 9,989,003 healthcare records were breached each month. In the year to August 31, 2024, there have been 491 data breaches of 500 or more records, and at least 58,668,002 records are known to have been breached. The average breach size in 2024 is currently 119,487 records, and the median breach size is 4,109 records.

Segment Analysis

The global diabetes management apps market is segmented based on subscription model, type of service, Operating System (OS) platform, application, and region.

Application:

Home-based diabetes management in the application segment is expected to dominate the diabetes management apps market with the highest market share.

Home-based management apps allow individuals to monitor blood glucose levels, track insulin usage, and manage their diet and physical activity without needing to visit healthcare providers regularly. This is particularly beneficial for individuals with busy lifestyles, older adults, or those living in remote areas where access to healthcare is limited. The rise of telemedicine and remote monitoring has further boosted home-based diabetes management. Healthcare providers are now able to remotely monitor patients' health data in real time, leading to more personalized and timely interventions.

For instance, in November 2024, PureHealth revealed a huge surge in users of Pura, the group’s AI-enabled app. Pura launched a highly anticipated diabetes care module that simplifies diabetes management by offering real-time glucose tracking and personalized meal plans. Patients can manage their entire healthcare journey, from appointments and follow-ups to home medicine delivery and payment options, including self-pay and insurance integration. In the future, the app will enable users to arrange home sample collections for their routine tests, along with other new tools to enhance the patient journey.

Home-based apps offer personalized insights based on data collected from users, such as blood sugar levels, meals, exercise, and medication. This allows users to make real-time adjustments and helps prevent complications associated with diabetes. For instance, Glooko is a diabetes management app that provides personalized insights by integrating data from glucose meters, wearables, and fitness trackers. This allows users to better understand the impact of their daily activities on their blood sugar levels, enabling more informed decision-making.

Geographical Analysis

North America is expected to hold a significant position in the diabetes management apps market with the highest market share

North America, particularly the United States, has one of the highest rates of diabetes, creating a large market for diabetes management apps. According to the American Diabetes Association (ADA), more than 38 million Americans have diabetes, with an additional 96 million having prediabetes. This high number of individuals with diabetes drives the demand for digital tools to manage the condition.

North American companies are leading the way in terms of technological advancements in diabetes care, integrating artificial intelligence (AI), machine learning, and wearable devices with diabetes apps. These technologies help users better understand their condition and manage it more effectively. For instance, the Dexcom G6 CGM system, a product used in conjunction with diabetes management apps, provides real-time glucose monitoring and integrates with mobile apps for continuous tracking. This system is widely used across North America, with the company being headquartered in the U.S.

Competitive Landscape

The major global players in the diabetes management apps market include Welldoc, Inc., Omada Health Inc., Glooko, Inc., Azumio Inc., Abbott Laboratories, mySugr GmbH, SquareMed Software GmbH, Health2Sync, iHealth Labs Inc., and SIRMA MEDICAL SYSTEMS AD, among others.

Why Purchase the Report?
• Pipeline & Innovations: Reviews ongoing clinical trials, product pipelines, and forecasts upcoming advancements in medical devices and pharmaceuticals.
• Product Performance & Market Positioning: Analyze product performance, market positioning, and growth potential to optimize strategies.
• Real-World Evidence: Integrates patient feedback and data into product development for improved outcomes.
• Physician Preferences & Health System Impact: Examines healthcare provider behaviors and the impact of health system mergers on adoption strategies.
• Market Updates & Industry Changes: This covers recent regulatory changes, new policies, and emerging technologies.
• Competitive Strategies: Analyze competitor strategies, market share, and emerging players.
• Pricing & Market Access: Reviews pricing models, reimbursement trends, and market access strategies.
• Market Entry & Expansion: Identifies optimal strategies for entering new markets and partnerships.
• Regional Growth & Investment: Highlights high-growth regions and investment opportunities.
• Supply Chain Optimization: Assesses supply chain risks and distribution strategies for efficient product delivery.
• Sustainability & Regulatory Impact: Focuses on eco-friendly practices and evolving regulations in healthcare.
• Post-market Surveillance: Uses post-market data to enhance product safety and access.
• Pharmacoeconomics & Value-Based Pricing: Analyzes the shift to value-based pricing and data-driven decision-making in R&D.

The global diabetes management apps market report delivers a detailed analysis with 70 key tables, more than 58 visually impactful figures, and 192 pages of expert insights, providing a complete view of the market landscape.

Target Audience 2024
• Manufacturers: Pharmaceutical, Medical Device, Biotech Companies, Contract Manufacturers, Distributors, Hospitals.
• Regulatory & Policy: Compliance Officers, Government, Health Economists, Market Access Specialists.
• Technology & Innovation: AI/Robotics Providers, R&D Professionals, Clinical Trial Managers, Pharmacovigilance Experts.
• Investors: Healthcare Investors, Venture Fund Investors, Pharma Marketing & Sales.
• Consulting & Advisory: Healthcare Consultants, Industry Associations, Analysts.
• Supply Chain: Distribution and Supply Chain Managers.
• Consumers & Advocacy: Patients, Advocacy Groups, Insurance Companies.
• Academic & Research: Academic Institutions.

1. Market Introduction and Scope: 1.1. Objectives of the Report; 1.2. Report Coverage & Definitions; 1.3. Report Scope
2. Executive Insights and Key Takeaways: 2.1. Market Highlights and Strategic Takeaways; 2.2. Key Trends and Future Projections; 2.3. Snippet by Subscription Model; 2.4. Snippet by Type of Service; 2.5. Snippet by Operating System (OS) Platform; 2.6. Snippet by Application; 2.7. Snippet by Region
3. Dynamics: 3.1. Impacting Factors; 3.1.1. Drivers; 3.1.1.1. Rising Prevalence of Diabetes; 3.1.1.2. Rising Technological Advancements; 3.1.1.3. XX; 3.1.2. Restraints; 3.1.2.1. Data Privacy and Security Concerns; 3.1.2.2. Regulatory Scrutiny and Compliance; 3.1.2.3. XX; 3.1.3. Opportunity; 3.1.3.1. AI and Machine Learning for Personalized Diabetes Care; 3.1.3.2. XX; 3.1.4. Impact Analysis
4. Strategic Insights and Industry Outlook: 4.1. Market Leaders and Pioneers; 4.1.1. Emerging Pioneers and Prominent Players; 4.1.2. Established leaders with largest selling Brand; 4.1.3. Market leaders with established Product; 4.2. CXO Perspectives; 4.3. Latest Developments and Breakthroughs; 4.4. Case Studies/Ongoing Research; 4.5. Regulatory and Reimbursement Landscape; 4.5.1. North America; 4.5.2. Europe; 4.5.3. Asia Pacific; 4.5.4. Latin America; 4.5.5. Middle East & Africa; 4.6. Porter’s Five Forces Analysis; 4.7. Patent Analysis; 4.8. SWOT Analysis; 4.9. Unmet Needs and Gaps; 4.10. Recommended Strategies for Market Entry and Expansion; 4.11. Scenario Analysis: Best-Case, Base-Case, and Worst-Case Forecasts; 4.12. Pricing Analysis and Price Dynamics; 4.13. Technology and Trend Analysis
5. Diabetes Management Apps Market, By Subscription Model: 5.1. Introduction; 5.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Subscription Model; 5.1.2. Market Attractiveness Index, By Subscription Model; 5.2. Free Subscription Model*; 5.2.1. Introduction; 5.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%); 5.3. Paid Subscription Model
6. Diabetes Management Apps Market, By Type of Service: 6.1. Introduction; 6.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type of Service; 6.1.2. Market Attractiveness Index, By Type of Service; 6.2. Digital Diabetes Management*; 6.2.1. Introduction; 6.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%); 6.3. Diabetic Weight & Diet Management
7. Diabetes Management Apps Market, By Operating System (OS) Platform: 7.1. Introduction; 7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Operating System (OS) Platform; 7.1.2. Market Attractiveness Index, By Operating System (OS) Platform; 7.2. Android*; 7.2.1. Introduction; 7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%); 7.3. iOS
8. Diabetes Management Apps Market, By Application: 8.1. Introduction; 8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application; 8.1.2. Market Attractiveness Index, By Application; 8.2. Home-Based Diabetes Management*; 8.2.1. Introduction; 8.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%); 8.3. AI-Based Predictive Diabetes Analytics
9. Diabetes Management Apps Market, By Regional Market Analysis and Growth Opportunities: 9.1. Introduction; 9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region; 9.1.2. Market Attractiveness Index, By Region; 9.2. North America; 9.2.1. Introduction; 9.2.2. Key Region-Specific Dynamics; 9.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Subscription Model; 9.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type of Service; 9.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Operating System (OS) Platform; 9.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application; 9.2.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country; 9.2.7.1. U.S.; 9.2.7.2. Canada; 9.2.7.3. Mexico; 9.3. Europe; 9.3.1. Introduction; 9.3.2. Key Region-Specific Dynamics; 9.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Subscription Model; 9.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type of Service; 9.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Operating System (OS) Platform; 9.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application; 9.3.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country; 9.3.7.1. Germany; 9.3.7.2. U.K.; 9.3.7.3. France; 9.3.7.4. Spain; 9.3.7.5. Italy; 9.3.7.6. Rest of Europe; 9.4. South America; 9.4.1. Introduction; 9.4.2. Key Region-Specific Dynamics; 9.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Subscription Model; 9.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type of Service; 9.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Operating System (OS) Platform; 9.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application; 9.4.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country; 9.4.7.1. Brazil; 9.4.7.2. Argentina; 9.4.7.3. Rest of South America; 9.5. Asia-Pacific; 9.5.1. Introduction; 9.5.2. Key Region-Specific Dynamics; 9.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Subscription Model; 9.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type of Service; 9.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Operating System (OS) Platform; 9.5.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application; 9.5.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country; 9.5.7.1. China; 9.5.7.2. India; 9.5.7.3. Japan; 9.5.7.4. South Korea; 9.5.7.5. Rest of Asia-Pacific; 9.6. Middle East and Africa; 9.6.1. Introduction; 9.6.2. Key Region-Specific Dynamics; 9.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Subscription Model; 9.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type of Service; 9.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Operating System (OS) Platform; 9.6.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
10. Competitive Landscape and Market Positioning: 10.1. Competitive Overview and Key Market Players; 10.2. Market Share Analysis and Positioning Matrix; 10.3. Strategic Partnerships, Mergers & Acquisitions; 10.4. Key Developments in Product Portfolios and Innovations; 10.5. Company Benchmarking
11. Company Profiles: 11.1. Welldoc, Inc.*; 11.1.1. Company Overview; 11.1.2. Product Portfolio and Description; 11.1.3. Financial Overview; 11.1.4. Key Developments; 11.1.5. SWOT Analysis; 11.2. Omada Health Inc.; 11.3. Glooko, Inc.; 11.4. Azumio Inc.; 11.5. Abbott Laboratories; 11.6. mySugr GmbH; 11.7. SquareMed Software GmbH; 11.8. Health2Sync; 11.9. iHealth Labs Inc.; 11.10. SIRMA MEDICAL SYSTEMS AD; LIST NOT EXHAUSTIVE
12. Assumption and Research Methodology: 12.1. Data Collection Methods; 12.2. Data Triangulation; 12.3. Forecasting Techniques; 12.4. Data Verification and Validation
13. Appendix: 13.1. About Us and Services; 13.2. Contact Us